MLTX icon

MoonLake Immunotherapeutics

46 hedge funds and large institutions have $113M invested in MoonLake Immunotherapeutics in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
0.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
7
Reduced
9
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
GCL
26
Glazer Capital LLC
New York
$599K +$588K +56,748 +5,154%
Millennium Management
27
Millennium Management
New York
$577K +$370K +35,735 +179%
LGM
28
Logos Global Management
California
$518K -$1.55M -150,000 -75%
PCM
29
Prelude Capital Management
New York
$518K +$518K +50,000 New
MS
30
Maven Securities
Jersey
$513K
Janus Henderson Group
31
Janus Henderson Group
United Kingdom
$497K
TD Asset Management
32
TD Asset Management
Ontario, Canada
$444K
MWM
33
Meridian Wealth Management
Kentucky
$279K +$83.7K +8,100 +43%
RCM
34
Radcliffe Capital Management
Pennsylvania
$260K +$53.1K +5,131 +26%
EAM
35
Exos Asset Management
New York
$260K +$208K +20,100 +402%
ECM
36
ExodusPoint Capital Management
New York
$259K
Nomura Holdings
37
Nomura Holdings
Japan
$255K -$521 -51 -0.2%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$238K +$238K +23,013 New
CC
39
Caxton Corporation
New Jersey
$165K
HF
40
HRT Financial
New York
$147K
PAM
41
Panagora Asset Management
Massachusetts
$74K -$421 -41 -0.6%
Morgan Stanley
42
Morgan Stanley
New York
$61K -$10 -1 -0%
UBS Group
43
UBS Group
Switzerland
$4K +$4K +374 New
SCM
44
Silverarc Capital Management
Massachusetts
$2.42K +$57 +5,535 +2%
MF
45
Magnetar Financial
Illinois
$632 -$28 -2,747 -4%
HM
46
HealthCor Management
New York
-$613K -60,027 Closed
SCM
47
Suvretta Capital Management
New York
-$361K -35,344 Closed